Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by A Pleil
Real-World Health Care Expenditure in Hemophilia a Patients Using Standard and Extended Half-Life Recombinant Factor VIII Products
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Related publications
Psy65 - Real-World Data Analysis of Us Claims Data on Coagulation Factor Ix Dispensation and Expenditures in Patients With Severe Hemophilia B: Standard Half-Life vs. Extended Half-Life Products
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Successful Haemostasis With Extended Half-Life Recombinant Factor VIII in Circumcision
Turkish Journal of Haematology
Hematology
Discrepancies Between the One-Stage Clotting Assay and Chromogenic Assay in Patients With Hemophilia a Receiving Standard or Extended Half-Life Factor VIII Products in Clinical Settings
Thrombosis Research
Hematology
Perioperative Management of Hemophilia a Using Recombinant Factor VIII in Patients Undergoing Major or Minor Surgery
Blood
Biochemistry
Immunology
Cell Biology
Hematology
AMulticenter Clinical Study of Recombinant Factor VIII (BL-160) in Hemophilia a Patients
Japanese Journal of Thrombosis and Hemostasis
The Impact of Extended Half-Life Versus Conventional Factor Product on Hemophilia Caregiver Burden
Quality of Life Research
Environmental
Public Health
Occupational Health
Psy112 - Factor Utilization Analysis of Extended Duration and Standard-Acting Recombinant Fviii Treatments for Severe Hemophilia a in Sweden
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
A Multi-Center Post-Marketing Surveillance Study of Recombinant Factor VIII (Recombinate) in Previously Treated Patients With Hemophilia A
Japanese Journal of Thrombosis and Hemostasis
The Impact of Factor VIII/von Willebrand Factor Products in Inhibitor Development and Management of Patients With Hemophilia a With Inhibitors
Oncology & Hematology Review (US)
